RetinalGenix Technologies Inc. RTGN
$3.99
-$0.01-0.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -62.61% | -17.61% | -22.93% | 1.30% | 9.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -53.20% | 0.48% | -28.17% | -11.74% | -2.17% |
| Operating Income | 53.20% | -0.48% | 28.17% | 11.74% | 2.17% |
| Income Before Tax | 52.66% | -0.54% | 28.13% | 11.72% | 2.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.66% | -0.54% | 28.13% | 11.72% | 2.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.66% | -0.54% | 28.13% | 11.72% | 2.14% |
| EBIT | 53.20% | -0.48% | 28.17% | 11.74% | 2.17% |
| EBITDA | 53.20% | -0.49% | 28.16% | 11.74% | 2.16% |
| EPS Basic | 53.95% | 0.63% | 30.13% | 14.76% | 4.84% |
| Normalized Basic EPS | 53.85% | 0.51% | 30.10% | 14.73% | 4.74% |
| EPS Diluted | 53.95% | 0.63% | 30.13% | 14.76% | 4.84% |
| Normalized Diluted EPS | 53.85% | 0.51% | 30.10% | 14.73% | 4.74% |
| Average Basic Shares Outstanding | 2.63% | 1.25% | 2.72% | 3.39% | 2.59% |
| Average Diluted Shares Outstanding | 2.63% | 1.25% | 2.72% | 3.39% | 2.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |